Drugs Made In America Acquisition Corp. Ordinary Shares

NASDAQ:DMAA

Shell Companies

Financial Services
$10.90 +0.00%

+$0.00 today

Market cap
$264.62M
Beta
0.00
P/E (TTM)
36.7
EPS (TTM)
$0.29
52W Low $10.17High $10.63

Volume 0.00M

Average 0.11M

DMAA Other Non-Cash Items

Other non-cash adjustments that reconcile net income to operating cash flow.

Drugs Made In America Acquisition Corp. Ordinary SharesNASDAQ: DMAA

Other Non-Cash Items · Q1 FY2026 · quarter ended Mar 2026

Other non-cash items grows, but more slowly than its trailing trend

Q1 FY2026 other non-cash items of $2.08M (cash outflow) rose 39.8% year over year, behind the +231.1% change in trailing-twelve-month other non-cash items.

What to watch

Whether quarterly growth recovers from +39.8% toward the trailing-twelve-month pace of +231.1%.

Sources:Cash FlowText generated from reported figures; not investment advice.

Latest quarterMar 2026
-$2.08M-227.4% QoQ
Last fiscal yearDec 2025
-$4.65M+2602.0% YoY
LTMMar 2026
-$5.1M+231.1% YoY
Other Non-Cash Items past and forecast growth by horizon
Horizon Past Forecast Difference
Quarter+39.8%——
1 year+2602.0%——
3-year CAGR———
5-year CAGR——
10-year CAGR——

Other Non-Cash Items history

USD · from the cash flow

Latest · FY2025
(4.65M) USD
Year-over-year change
-2602.0%

Other Non-Cash Items vs competitors

How DMAA compares with its peers on the latest reported figures

  • DMAA's LTM Mar 2026 other non-cash items of $5.1M is the 9th largest of the 10 companies compared; the peer median is $8.44M.
  • Its year-over-year change of +231.1% is the 3rd highest of 5, against a peer median of +1219.4%.
DMAA Competitors Peer median
Other Non-Cash Items for DMAA and competitors
Company Period LTM YoY 3-year CAGR% of revenue
ALFCenturion Acquisition Corp.LTM Mar 2026$11.32M ———
MLACMountain Lake Acquisition Corp.FY2025$9.59M +2211.0%+26.2%—
SIMASIM Acquisition Corp. ILTM Mar 2026$9.34M +227.7%——
TACOUBerto Acquisition Corp. UnitFY2025$8.44M ———
TACOBerto Acquisition Corp.FY2025$8.44M ———
RTACRenatus Tactical Acquisition Corp I Class A Ordinary SharesLTM Mar 2026$7.9M ———
LOKVLive Oak Acquisition Corp. V Class A Ordinary SharesFY2025$7.38M +3906801.6%——
OYSEOyster Enterprises II Acquisition CorpFY2025$6.22M ———
DMAADrugs Made In America Acquisition Corp. Ordinary SharesLTM Mar 2026$5.1M +231.1%——
TACHTitan Acquisition Corp.LTM Mar 2026$2.96M -1458895.0%——
Peer median (excluding DMAA) $8.44M+1219.4%+26.2%—

Competitors are the stored peer set for DMAA. Fiscal calendars differ, so each company's latest period is shown. Text is generated from reported figures; not investment advice.

Drugs Made In America Acquisition Corp. Ordinary Shares

NASDAQ:DMAA

Intrinsic Alpha fair value

Locked

Current Price

$10.90

Margin of safety hidden

Unlock the intrinsic value to see where the current price sits on the valuation runway.

Valuation runway

Locked

Get the intrinsic value and margin of safety with a free account.